B. Riley Wealth Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Sell
14,925
-969
-6% -$86.5K 0.08% 218
2026
Q1
$1.11M Sell
15,894
-709
-4% -$54.6K 0.07% 265
2025
Q4
$1.32M Sell
16,603
-2,085
-11% -$164K 0.06% 288
2025
Q3
$1.41M Buy
18,688
+69
+0.4% +$4.73K 0.07% 276
2025
Q2
$1.28M Buy
+18,619
New +$1.22M 0.06% 293
2024
Q4
$1.24M Sell
27,518
-20,484
-43% -$1.15M 0.04% 390
2024
Q3
$3.02M Sell
48,002
-4,547
-9% -$265K 0.08% 232
2024
Q2
$3.1M Sell
52,549
-27,327
-34% -$1.71M 0.08% 237
2024
Q1
$5.58M Buy
79,876
+18,093
+29% +$1.38M 0.15% 144
2023
Q4
$4.88M Sell
61,783
-18,093
-23% -$1.29M 0.13% 172
2023
Q3
$5.58M Sell
79,876
-167,573
-68% -$11.9M 0.15% 144
2023
Q2
$17.1M Buy
247,449
+161,725
+189% +$11.5M 0.38% 52
2023
Q1
$6.37M Sell
85,724
-1,228
-1% -$103K 0.17% 139
2022
Q4
$8.1M Buy
86,952
+2,580
+3% +$249K 0.23% 95
2022
Q3
$8.05M Buy
84,372
+15,111
+22% +$1.5M 0.24% 89
2022
Q2
$6.42M Sell
69,261
-2,476
-3% -$242K 0.27% 82
2022
Q1
$7.26M Sell
71,737
-1,711
-2% -$180K 0.24% 89
2021
Q4
$7.58M Buy
73,448
+2,009
+3% +$186K 0.22% 98
2021
Q3
$6.06M Buy
71,439
+5,871
+9% +$492K 0.19% 110
2021
Q2
$5.45M Sell
65,568
-20,656
-24% -$1.69M 0.18% 136
2021
Q1
$6.47M Buy
86,224
+30,428
+55% +$2.22M 0.23% 98
2020
Q4
$3.81M Sell
55,796
-14,567
-21% -$947K 0.2% 115
2020
Q3
$4.18M Buy
70,363
+10,031
+17% +$624K 0.22% 102
2020
Q2
$3.92M Buy
60,332
+332
+0.6% +$20.9K 0.26% 98
2020
Q1
$3.56M Buy
60,000
+8,777
+17% +$586K 0.3% 76
2019
Q4
$3.81M Buy
51,223
+1,350
+3% +$94.8K 0.32% 73
2019
Q3
$3.15M Buy
49,873
+13,090
+36% +$776K 0.31% 69
2019
Q2
$2.01M Buy
36,783
+19,652
+115% +$1.06M 0.22% 93
2019
Q1
$925K Buy
17,131
+6,163
+56% +$380K 0.12% 195
2018
Q4
$720K Buy
10,968
+3,162
+41% +$236K 0.1% 214
2018
Q3
$616K Buy
7,806
+1,002
+15% +$71.6K 0.07% 296
2018
Q2
$440K Sell
6,804
-653
-9% -$43K 0.06% 359
2018
Q1
$466K Sell
7,457
-153
-2% -$11K 0.07% 327
2017
Q4
$554K Sell
7,610
-539
-7% -$39.2K 0.07% 289
2017
Q3
$665K Sell
8,149
-4,362
-35% -$345K 0.11% 205
2017
Q2
$1.01M Sell
12,511
-1,155
-8% -$91.2K 0.18% 147
2017
Q1
$1.07M Sell
13,666
-1,838
-12% -$147K 0.21% 123
2016
Q4
$1.23M Sell
15,504
-109
-0.7% -$8.82K 0.25% 106
2016
Q3
$1.39M Sell
15,613
-1,661
-10% -$157K 0.27% 91
2016
Q2
$1.66M Buy
17,274
+1,193
+7% +$119K 0.33% 63
2016
Q1
$1.67M Sell
16,081
-1,955
-11% -$190K 0.39% 63
2015
Q4
$1.76M Buy
18,036
+2,328
+15% +$228K 0.36% 69
2015
Q3
$1.52M Buy
15,708
+2,120
+16% +$223K 0.36% 62
2015
Q2
$1.43M Sell
13,588
-1,549
-10% -$158K 0.35% 66
2015
Q1
$1.56M Sell
15,137
-2,779
-16% -$281K 0.38% 60
2014
Q4
$14.4K Buy
17,916
+11,905
+198% +$1.05M 0.31% 52
2014
Q3
$478K Sell
6,011
-12,935
-68% -$1.02M 0.12% 217
2014
Q2
$1.05M Buy
18,946
+14,219
+301% +$1.07M 0.25% 82
2014
Q1
$354K Buy
4,727
+1,865
+65% +$132K 0.11% 229
2013
Q4
$205K Sell
2,862
-358
-11% -$23K 0.07% 339
2013
Q3
$183K Buy
3,220
+194
+6% +$11.6K 0.06% 362
2013
Q2
$173K Buy
+3,026
New +$175K 0.06% 390

Other funds holding CVS

B. Riley Wealth Advisors's CVS Position: Q2 2026 in Review

B. Riley Wealth Advisors reduced its CVS Health (CVS) stake by 6.1% in Q2 2026, selling an estimated $86.5K and leaving 14,925 shares worth $1.55M. The position accounts for 0.08% of the portfolio, ranked #218.

B. Riley Wealth Advisors first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.1M in Q2 2023. 458 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • B. Riley Wealth Advisors held 14,925 shares of CVS Health worth $1.55M as of Q2 2026.
  • B. Riley Wealth Advisors sold 969 CVS Health shares in Q2 2026, an estimated $86.5K.
  • CVS Health made up 0.08% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #218 holding.
  • B. Riley Wealth Advisors first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • B. Riley Wealth Advisors's CVS Health position peaked at $17.1M in Q2 2023.
  • 458 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.